Skip to main content
. 2021 Jan 18;35(5):1057–1066. doi: 10.1007/s10557-020-07134-2

Fig. 6.

Fig. 6

Subgroup analysis of different doses in the change of serum potassium (sK+) between the ZS-9 and placebo group at correction phase (48 h) after start of treatment. SZC, Sodium zirconium cyclosilicate; tid: three times daily